These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 11016336

  • 1. Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis.
    Jones DR, Broad RM, Madrid LV, Baldwin AS, Mayo MW.
    Ann Thorac Surg; 2000 Sep; 70(3):930-6; discussion 936-7. PubMed ID: 11016336
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of nuclear factor kappaB chemosensitizes non-small cell lung cancer through cytochrome c release and caspase activation.
    Jones DR, Broad RM, Comeau LD, Parsons SJ, Mayo MW.
    J Thorac Cardiovasc Surg; 2002 Feb; 123(2):310-7. PubMed ID: 11828291
    [Abstract] [Full Text] [Related]

  • 3. Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine-induced apoptosis.
    Denlinger CE, Rundall BK, Keller MD, Jones DR.
    Ann Thorac Surg; 2004 Oct; 78(4):1207-14; discussion 1207-14. PubMed ID: 15464472
    [Abstract] [Full Text] [Related]

  • 4. Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer.
    Rundall BK, Denlinger CE, Jones DR.
    Surgery; 2005 Aug; 138(2):360-7. PubMed ID: 16153448
    [Abstract] [Full Text] [Related]

  • 5. The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1.
    Kim MK, Jeon YK, Woo JK, Choi Y, Choi DH, Kim YH, Kim CW.
    Mol Cancer; 2011 Aug 16; 10():98. PubMed ID: 21843371
    [Abstract] [Full Text] [Related]

  • 6. Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death.
    Rundall BK, Denlinger CE, Jones DR.
    Surgery; 2004 Aug 16; 136(2):416-25. PubMed ID: 15300209
    [Abstract] [Full Text] [Related]

  • 7. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer.
    Song L, Xiong H, Li J, Liao W, Wang L, Wu J, Li M.
    Clin Cancer Res; 2011 Apr 01; 17(7):1839-49. PubMed ID: 21325072
    [Abstract] [Full Text] [Related]

  • 8. Sulindac enhances tumor necrosis factor-alpha-mediated apoptosis of lung cancer cell lines by inhibition of nuclear factor-kappaB.
    Berman KS, Verma UN, Harburg G, Minna JD, Cobb MH, Gaynor RB.
    Clin Cancer Res; 2002 Feb 01; 8(2):354-60. PubMed ID: 11839649
    [Abstract] [Full Text] [Related]

  • 9. Blocking NF-κB sensitizes non-small cell lung cancer cells to histone deacetylase inhibitor induced extrinsic apoptosis through generation of reactive oxygen species.
    Karthik S, Sankar R, Varunkumar K, Anusha C, Ravikumar V.
    Biomed Pharmacother; 2015 Feb 01; 69():337-44. PubMed ID: 25661379
    [Abstract] [Full Text] [Related]

  • 10. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling.
    Wang LH, Li Y, Yang SN, Wang FY, Hou Y, Cui W, Chen K, Cao Q, Wang S, Zhang TY, Wang ZZ, Xiao W, Yang JY, Wu CF.
    Br J Cancer; 2014 Jan 21; 110(2):341-52. PubMed ID: 24300974
    [Abstract] [Full Text] [Related]

  • 11. Combination chemotherapy of nafamostat mesilate with gemcitabine for pancreatic cancer targeting NF-kappaB activation.
    Uwagawa T, Chiao PJ, Gocho T, Hirohara S, Misawa T, Yanaga K.
    Anticancer Res; 2009 Aug 21; 29(8):3173-8. PubMed ID: 19661331
    [Abstract] [Full Text] [Related]

  • 12. Inducible nuclear factor-kappaB activation contributes to chemotherapy resistance in gastric cancer.
    Camp ER, Li J, Minnich DJ, Brank A, Moldawer LL, MacKay SL, Hochwald SN.
    J Am Coll Surg; 2004 Aug 21; 199(2):249-58. PubMed ID: 15275881
    [Abstract] [Full Text] [Related]

  • 13. Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death.
    Arlt A, Gehrz A, Müerköster S, Vorndamm J, Kruse ML, Fölsch UR, Schäfer H.
    Oncogene; 2003 May 22; 22(21):3243-51. PubMed ID: 12761494
    [Abstract] [Full Text] [Related]

  • 14. Paclitaxel efficacy is increased by parthenolide via nuclear factor-kappaB pathways in in vitro and in vivo human non-small cell lung cancer models.
    Gao ZW, Zhang DL, Guo CB.
    Curr Cancer Drug Targets; 2010 Nov 22; 10(7):705-15. PubMed ID: 20578985
    [Abstract] [Full Text] [Related]

  • 15. Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing.
    Siena L, Pace E, Ferraro M, Di Sano C, Melis M, Profita M, Spatafora M, Gjomarkaj M.
    Immunology; 2014 Feb 22; 141(2):242-55. PubMed ID: 24128051
    [Abstract] [Full Text] [Related]

  • 16. Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts.
    Waters JA, Matos J, Yip-Schneider M, Aguilar-Saavedra JR, Crean CD, Beane JD, Dumas RP, Suvannasankha A, Schmidt CM.
    Surgery; 2015 Oct 22; 158(4):881-8; discussion 888-9. PubMed ID: 26209568
    [Abstract] [Full Text] [Related]

  • 17. {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.
    Kunnumakkara AB, Sung B, Ravindran J, Diagaradjane P, Deorukhkar A, Dey S, Koca C, Yadav VR, Tong Z, Gelovani JG, Guha S, Krishnan S, Aggarwal BB.
    Cancer Res; 2010 Nov 01; 70(21):8695-705. PubMed ID: 20864511
    [Abstract] [Full Text] [Related]

  • 18. Plumbagin from Plumbago Zeylanica L induces apoptosis in human non-small cell lung cancer cell lines through NF- κB inactivation.
    Xu TP, Shen H, Liu LX, Shu YQ.
    Asian Pac J Cancer Prev; 2013 Nov 01; 14(4):2325-31. PubMed ID: 23725135
    [Abstract] [Full Text] [Related]

  • 19. Effect of hyperthermia combined with gemcitabine on apoptotic cell death in cultured human pancreatic cancer cell lines.
    Adachi S, Kokura S, Okayama T, Ishikawa T, Takagi T, Handa O, Naito Y, Yoshikawa T.
    Int J Hyperthermia; 2009 May 01; 25(3):210-9. PubMed ID: 19437237
    [Abstract] [Full Text] [Related]

  • 20. Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation.
    Iwase R, Haruki K, Fujiwara Y, Furukawa K, Shiba H, Uwagawa T, Misawa T, Ohashi T, Yanaga K.
    J Surg Res; 2013 Sep 01; 184(1):605-12. PubMed ID: 23830367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.